Cargando…

Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology

OBJECTIVE: The purpose of this work is to study the mechanism of action of Duhuo Jisheng Decoction (DHJSD) in the treatment of osteoporosis based on the methods of bioinformatics and network pharmacology. METHODS: In this study, the active compounds of each medicinal ingredient of DHJSD and their co...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Zhencheng, Zheng, Can, Chang, Yanan, Liu, Kuankuan, Shu, Li, Zhang, Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046540/
https://www.ncbi.nlm.nih.gov/pubmed/33880122
http://dx.doi.org/10.1155/2021/5510290
_version_ 1783678871372038144
author Xiong, Zhencheng
Zheng, Can
Chang, Yanan
Liu, Kuankuan
Shu, Li
Zhang, Chi
author_facet Xiong, Zhencheng
Zheng, Can
Chang, Yanan
Liu, Kuankuan
Shu, Li
Zhang, Chi
author_sort Xiong, Zhencheng
collection PubMed
description OBJECTIVE: The purpose of this work is to study the mechanism of action of Duhuo Jisheng Decoction (DHJSD) in the treatment of osteoporosis based on the methods of bioinformatics and network pharmacology. METHODS: In this study, the active compounds of each medicinal ingredient of DHJSD and their corresponding targets were obtained from TCMSP database. Osteoporosis was treated as search query in GeneCards, MalaCards, DisGeNET, Therapeutic Target Database (TTD), Comparative Toxicogenomics Database (CTD), and OMIM databases to obtain disease-related genes. The overlapping targets of DHJSD and osteoporosis were identified, and then GO and KEGG enrichment analysis were performed. Cytoscape was employed to construct DHJSD-compounds-target genes-osteoporosis network and protein-protein interaction (PPI) network. CytoHubba was utilized to select the hub genes. The activities of binding of hub genes and key components were confirmed by molecular docking. RESULTS: 174 active compounds and their 205 related potential targets were identified in DHJSD for the treatment of osteoporosis, including 10 hub genes (AKT1, ALB, IL6, MAPK3, VEGFA, JUN, CASP3, EGFR, MYC, and EGF). Pathway enrichment analysis of target proteins indicated that osteoclast differentiation, AGE-RAGE signaling pathway in diabetic complications, Wnt signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, calcium signaling pathway, and TNF signaling pathway were the specifically major pathways regulated by DHJSD against osteoporosis. Further verification based on molecular docking results showed that the small molecule compounds (Quercetin, Kaempferol, Beta-sitosterol, Beta-carotene, and Formononetin) contained in DHJSD generally have excellent binding affinity to the macromolecular target proteins encoded by the top 10 genes. CONCLUSION: This study reveals the characteristics of multi-component, multi-target, and multi-pathway of DHJSD against osteoporosis and provides novel insights for verifying the mechanism of DHJSD in the treatment of osteoporosis.
format Online
Article
Text
id pubmed-8046540
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-80465402021-04-19 Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology Xiong, Zhencheng Zheng, Can Chang, Yanan Liu, Kuankuan Shu, Li Zhang, Chi Evid Based Complement Alternat Med Research Article OBJECTIVE: The purpose of this work is to study the mechanism of action of Duhuo Jisheng Decoction (DHJSD) in the treatment of osteoporosis based on the methods of bioinformatics and network pharmacology. METHODS: In this study, the active compounds of each medicinal ingredient of DHJSD and their corresponding targets were obtained from TCMSP database. Osteoporosis was treated as search query in GeneCards, MalaCards, DisGeNET, Therapeutic Target Database (TTD), Comparative Toxicogenomics Database (CTD), and OMIM databases to obtain disease-related genes. The overlapping targets of DHJSD and osteoporosis were identified, and then GO and KEGG enrichment analysis were performed. Cytoscape was employed to construct DHJSD-compounds-target genes-osteoporosis network and protein-protein interaction (PPI) network. CytoHubba was utilized to select the hub genes. The activities of binding of hub genes and key components were confirmed by molecular docking. RESULTS: 174 active compounds and their 205 related potential targets were identified in DHJSD for the treatment of osteoporosis, including 10 hub genes (AKT1, ALB, IL6, MAPK3, VEGFA, JUN, CASP3, EGFR, MYC, and EGF). Pathway enrichment analysis of target proteins indicated that osteoclast differentiation, AGE-RAGE signaling pathway in diabetic complications, Wnt signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, calcium signaling pathway, and TNF signaling pathway were the specifically major pathways regulated by DHJSD against osteoporosis. Further verification based on molecular docking results showed that the small molecule compounds (Quercetin, Kaempferol, Beta-sitosterol, Beta-carotene, and Formononetin) contained in DHJSD generally have excellent binding affinity to the macromolecular target proteins encoded by the top 10 genes. CONCLUSION: This study reveals the characteristics of multi-component, multi-target, and multi-pathway of DHJSD against osteoporosis and provides novel insights for verifying the mechanism of DHJSD in the treatment of osteoporosis. Hindawi 2021-04-05 /pmc/articles/PMC8046540/ /pubmed/33880122 http://dx.doi.org/10.1155/2021/5510290 Text en Copyright © 2021 Zhencheng Xiong et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xiong, Zhencheng
Zheng, Can
Chang, Yanan
Liu, Kuankuan
Shu, Li
Zhang, Chi
Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology
title Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology
title_full Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology
title_fullStr Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology
title_full_unstemmed Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology
title_short Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology
title_sort exploring the pharmacological mechanism of duhuo jisheng decoction in treating osteoporosis based on network pharmacology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046540/
https://www.ncbi.nlm.nih.gov/pubmed/33880122
http://dx.doi.org/10.1155/2021/5510290
work_keys_str_mv AT xiongzhencheng exploringthepharmacologicalmechanismofduhuojishengdecoctionintreatingosteoporosisbasedonnetworkpharmacology
AT zhengcan exploringthepharmacologicalmechanismofduhuojishengdecoctionintreatingosteoporosisbasedonnetworkpharmacology
AT changyanan exploringthepharmacologicalmechanismofduhuojishengdecoctionintreatingosteoporosisbasedonnetworkpharmacology
AT liukuankuan exploringthepharmacologicalmechanismofduhuojishengdecoctionintreatingosteoporosisbasedonnetworkpharmacology
AT shuli exploringthepharmacologicalmechanismofduhuojishengdecoctionintreatingosteoporosisbasedonnetworkpharmacology
AT zhangchi exploringthepharmacologicalmechanismofduhuojishengdecoctionintreatingosteoporosisbasedonnetworkpharmacology